Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes — Stella

Home/Preeclampsia/Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes

View on ClinicalTrials.gov

Recruiting

Back to Preeclampsia trials

Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes

Trial locations(1 site)

Turkey (Türkiye)

Ümraniye Eğitim ve Araştırma Hastanesi, Istanbul, Ümraniye

Key details

Sponsor

Umraniye Education and Research Hospital

Enrollment target

~88 participants

Started

March 2023

Primary completion

November 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 39 Years

Sex

Female only

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.